President and CEO
Wayne has held numerous, senior positions in multi-national companies and has lived in seven countries during the past 25 years. Through his career, he has been responsible for building and managing multibillion dollar businesses throughout the world, including mergers, integrations, acquisitions and major restructures as President and CEO.
From 2005 to 2013 he held senior positions at Merck KGaA, most recently as President of Europe, Canada and Australia. Prior to this, he was President of Emerging Markets, President of Japan and Global Head of Cardiovascular medicine.
Between 1999 and 2005, Wayne served at Roche Pharmaceuticals where he was Head of Pharmaceuticals in Roche’s South Korean operation, following his role as Head of Commercial Operations for Roche China based in Shanghai.
From April 2015 until November 2016, Wayne served as a Non-Executive Director of Cepheid (NASDAQ: CHPD), a molecular diagnostics company based in California.
He holds an MBA from the University of Southern Queensland, and a degree in business studies from the Queensland University of Technology.
He has also studied business courses at North Western University (Kellog School of Management) in Chicago, IMD Business School in Switzerland, INSEAD in France and Hong Kong University of Technology.
David St Denis
Chief Operating Officer
David is an accomplished senior healthcare leader with a systematic and metrics-driven approach spanning 20 years of proven business results at the regional and global levels within the life sciences and pharmaceutical sectors.
Most recently at Merck in Germany, he headed commercial operations for Europe and Canada. He has an extensive track record in charge of complex cross-functional and multi-cultural teams that have achieved impressive business objectives in both mature markets (US, Europe, Japan) and developing markets (Brazil, Russia, India, China and Mexico).
His core competencies include operations management, strategy development, marketing and sales, new product introduction and launch excellence, market access and pricing.
David has a Bachelor of Science from the University of Connecticut, a Masters of Arts from Boston University and an MBA in Global Management and International Marketing from Babson College – Franklin W. Olin Graduate School of Business.
Chief Financial Officer
Catherine Costello brings more than 20 years of experience in Australian and multinational businesses and joins Admedus from an emerging ASX-listed company, where she served as Chief Financial Officer and Company Secretary.
Prior to this role, she was Group Financial Controller with a global service provider operating in 32 international jurisdictions, responsible for the global finance, reporting, tax and treasury teams.
Preceding this, she worked for US-listed entities both at the head office and regional office levels in senior financial management roles.
She has a Commerce degree from the University of Queensland, a Masters of Science from Curtin University, is a Chartered Accountant and Chartered Secretary and is a graduate of both the Australian Institute of Company Directors and the Governance Institute of Australia. She also serves on a number of community based committees.